Toledo Data Fail To Give Galapagos A Lift
Underwhelming Results For Lead SIK Inhibitor
Lead Toledo compound GLPG3970 has failed to live up to expectations in three clinical studies, setting Galapagos's pipeline plans back and causing further concern among the investment community.
